These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37842826)

  • 1. Immunomodulatory interventions for focal epilepsy.
    Panebianco M; Walker L; Marson AG
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD009945. PubMed ID: 37842826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Ramaratnam S; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001909. PubMed ID: 32196639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD005612. PubMed ID: 35349176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vigabatrin add-on therapy for drug-resistant focal epilepsy.
    Bresnahan R; Gianatsi M; Maguire MJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007302. PubMed ID: 32730657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rufinamide add-on therapy for drug-resistant epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD011501. PubMed ID: 35285519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacosamide add-on therapy for focal epilepsy.
    Babar RK; Bresnahan R; Gillespie CS; Michael BD
    Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011772. PubMed ID: 29691835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Weston J; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001415. PubMed ID: 30357813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R; Atim-Oluk M; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012433. PubMed ID: 32129501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stiripentol add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Igwe SC; Bragazzi NL
    Cochrane Database Syst Rev; 2020 May; 5(5):CD009887. PubMed ID: 32468572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011501. PubMed ID: 30920649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.
    Chang XC; Yuan H; Wang Y; Xu HQ; Hong WK; Zheng RY
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD008907. PubMed ID: 34155624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felbamate add-on therapy for drug-resistant focal epilepsy.
    Shi LL; Bresnahan R; Martin-McGill KJ; Dong J; Ni H; Geng J
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008295. PubMed ID: 35914010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carisbamate add-on therapy for drug-resistant focal epilepsy.
    Lu C; Zheng J; Cao Y; Bresnahan R; Martin-McGill KJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012121. PubMed ID: 34870321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007783. PubMed ID: 32609387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.